Free Trial
NASDAQ:CDNA

CareDx (CDNA) Stock Price, News & Analysis

CareDx logo
$19.49 +0.64 (+3.40%)
Closing price 04:00 PM Eastern
Extended Trading
$19.08 -0.40 (-2.08%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About CareDx Stock (NASDAQ:CDNA)

Key Stats

Today's Range
$18.57
$19.70
50-Day Range
$14.18
$20.08
52-Week Range
$14.09
$34.84
Volume
839,840 shs
Average Volume
917,727 shs
Market Capitalization
$1.09 billion
P/E Ratio
16.95
Dividend Yield
N/A
Price Target
$30.33
Consensus Rating
Moderate Buy

Company Overview

CareDx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
87th Percentile Overall Score

CDNA MarketRank™: 

CareDx scored higher than 87% of companies evaluated by MarketBeat, and ranked 138th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CareDx has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    CareDx has only been the subject of 3 research reports in the past 90 days.

  • Read more about CareDx's stock forecast and price target.
  • Earnings Growth

    Earnings for CareDx are expected to grow in the coming year, from ($0.90) to ($0.41) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CareDx is 16.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.19.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CareDx is 16.96, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.20.

  • Price to Book Value per Share Ratio

    CareDx has a P/B Ratio of 2.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about CareDx's valuation and earnings.
  • Percentage of Shares Shorted

    12.10% of the float of CareDx has been sold short.
  • Short Interest Ratio / Days to Cover

    CareDx has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in CareDx has recently decreased by 3.38%, indicating that investor sentiment is improving.
  • Dividend Yield

    CareDx does not currently pay a dividend.

  • Dividend Growth

    CareDx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.10% of the float of CareDx has been sold short.
  • Short Interest Ratio / Days to Cover

    CareDx has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in CareDx has recently decreased by 3.38%, indicating that investor sentiment is improving.
  • News Sentiment

    CareDx has a news sentiment score of 1.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for CareDx this week, compared to 6 articles on an average week.
  • Search Interest

    3 people have searched for CDNA on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CareDx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,238,811.00 in company stock.

  • Percentage Held by Insiders

    Only 4.40% of the stock of CareDx is held by insiders.

  • Read more about CareDx's insider trading history.
Receive CDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter.

CDNA Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
CareDx (NASDAQ:CDNA) and bioMerieux (OTCMKTS:BMXMF) Head-To-Head Review
See More Headlines

CDNA Stock Analysis - Frequently Asked Questions

CareDx's stock was trading at $21.41 at the beginning of the year. Since then, CDNA shares have decreased by 8.9% and is now trading at $19.5050.
View the best growth stocks for 2025 here
.

CareDx, Inc. (NASDAQ:CDNA) issued its quarterly earnings data on Wednesday, April, 30th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.03. The company's revenue was up 17.6% on a year-over-year basis.
Read the conference call transcript
.

Shares of CDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CareDx investors own include Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Home Depot (HD).

Company Calendar

Last Earnings
4/30/2025
Today
7/02/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:CDNA
Employees
740
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$30.33
High Stock Price Target
$40.00
Low Stock Price Target
$24.00
Potential Upside/Downside
+55.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Trailing P/E Ratio
16.95
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$52.55 million
Pretax Margin
18.05%

Debt

Sales & Book Value

Annual Sales
$333.79 million
Cash Flow
$1.36 per share
Price / Cash Flow
14.37
Book Value
$7.06 per share
Price / Book
2.76

Miscellaneous

Free Float
53,231,000
Market Cap
$1.09 billion
Optionable
Optionable
Beta
2.19

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:CDNA) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners